Cytokinetics Inc. buy Needham & Company LLC
Start price
27.12.23
/
50%
€73.50
Target price
27.12.24
€97.23
Performance (%)
-17.69%
Price
12:18
€60.50
Summary
This prediction is currently active. The prediction for Cytokinetics Inc. disappoints with a performance of -17.69%. This prediction currently runs until 27.12.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | -3.150% | -3.150% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Needham & Company LLC from $60.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24